|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Pediatrics, Case Western Reserve University, Cleveland, Ohio, United States; Physiology & Biophysics, Case Western Reserve University, Cleveland, Ohio, United States; Pharmacology, Case Western Reserve University, Cleveland, Ohio, United States; Molecular Biology & Microbiology, Case Western Reserve University, Cleveland, Ohio, United States; Medicine and Physiology, University of California, San Francisco, California, United States
* To whom correspondence should be addressed. E-mail: aura.perez{at}case.edu.
Primary airway epithelial cells grown in air-liquid interface differentiate into cultures that resemble native epithelium morphologically, express ion transport similar to those in vivo, and secrete cytokines in response to stimuli. Comparisons of cultures derived from normal and CF individuals are difficult to interpret due to genetic differences besides CFTR. The recently discovered CFTR inhibitor, CFTRinh-172, was used to create a CF model with its own control to test if loss of CFTR-Cl- conductance alone was sufficient to initiate the CF inflammatory response. Continuous inhibition of CFTR-Cl- conductance for 3-5 days resulted in significant increase in IL-8 secretion at basal (p = 0.006) and in response to 109 Pseudomonas (p = 0.0001), a four-fold decrease in Smad3 expression (p = 0.02), a 3-fold increase in RhoA expression, and increased NF-
B nuclear translocation upon TNF
/IL-1
stimulation (p < 0.000001). CFTR inhibition by CFTRinh-172 over this period does not increase ENaC activity, so lack of Cl- conductance alone can mimic the inflammatory CF phenotype. CFTRinh-172 does not affect IL-8, IL-6 or GM-CSF secretion in two CF phenotype immortalized cell lines: 9/HTEo- pCEP-R and 16HBE14o- AS, or IL-8 secretion in primary CF cells, and inhibitor withdrawal abolishes the increased response, so CFTRinh-172 effects on cytokines are not direct. Five-day treatment with CFTRinh-172 does not affect cells deleteriously as evidenced by LDH, trypan blue, ciliary activity, EM histology, and inhibition reversibility. Our results support the hypothesis that lack of CFTR activity is responsible for the onset of the inflammatory cascade in the CF lung.
This article has been cited by other articles:
![]() |
N. T. N. Trinh, A. Prive, E. Maille, J. Noel, and E. Brochiero EGF and K+ channel activity control normal and cystic fibrosis bronchial epithelia repair Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L866 - L880. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Manson, D. A. Corey, N. M. White, and T. J. Kelley cAMP-mediated regulation of cholesterol accumulation in cystic fibrosis and Niemann-Pick type C cells Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L809 - L819. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Perez, A. M. van Heeckeren, D. Nichols, S. Gupta, J. F. Eastman, and P. B. Davis Peroxisome proliferator-activated receptor-{gamma} in cystic fibrosis lung epithelium Am J Physiol Lung Cell Mol Physiol, August 1, 2008; 295(2): L303 - L313. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Chappell, M. Bunz, E. Smoll, H. Dong, C. Lytle, K. E. Barrett, and D. F. McCole Hydrogen peroxide inhibits Ca2+-dependent chloride secretion across colonic epithelial cells via distinct kinase signaling pathways and ion transport proteins FASEB J, June 1, 2008; 22(6): 2023 - 2036. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mizumori, Y. Choi, P. H. Guth, E. Engel, J. D. Kaunitz, and Y. Akiba CFTR inhibition augments NHE3 activity during luminal high CO2 exposure in rat duodenal mucosa Am J Physiol Gastrointest Liver Physiol, June 1, 2008; 294(6): G1318 - G1327. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Miller and P. B. Davis FXYD5 modulates Na+ absorption and is increased in cystic fibrosis airway epithelia Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L654 - L664. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. J. Broughton-Head, J. Shur, M. P. Carroll, J. R. Smith, and J. K. Shute Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1240 - L1249. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hybiske, Z. Fu, C. Schwarzer, J. Tseng, J. Do, N. Huang, and T. E. Machen Effects of cystic fibrosis transmembrane conductance regulator and {Delta}F508CFTR on inflammatory response, ER stress, and Ca2+ of airway epithelia Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1250 - L1260. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Routaboul, C. Norez, P. Melin, M.-C. Molina, B. Boucherle, F. Bossard, S. Noel, R. Robert, C. Gauthier, F. Becq, et al. Discovery of {alpha}-Aminoazaheterocycle-Methylglyoxal Adducts as a New Class of High-Affinity Inhibitors of Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channels J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1023 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chatterjee, S. Baeter, and J. Bhattacharya Endothelial and epithelial signaling in the lung Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L517 - L519. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Sagel, J. F. Chmiel, and M. W. Konstan Sputum Biomarkers of Inflammation in Cystic Fibrosis Lung Disease Proceedings of the ATS, August 1, 2007; 4(4): 406 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Dechecchi, E. Nicolis, V. Bezzerri, A. Vella, M. Colombatti, B. M. Assael, Y. Mettey, M. Borgatti, I. Mancini, R. Gambari, et al. MPB-07 Reduces the Inflammatory Response to Pseudomonas aeruginosa in Cystic Fibrosis Bronchial Cells Am. J. Respir. Cell Mol. Biol., May 1, 2007; 36(5): 615 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Rubin CFTR is a modulator of airway inflammation Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L381 - L382. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |